Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 study

Pawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, Vijay Goni, Arun Kumar Sharma, Sujit Kumar Tripathy, Keerthi Talari, Vivek Pandey, Parag Kantilal Sancheti, Saurabh Singh, Syamasis Bandyopadhyay, Naresh Shetty, Surendra Umesh Kamath, Purohit Sharad Prahaldbhai, Jijy Abraham, Suresh Kannan, Nikhil N. Verma, Uday Kumar

Open source

DOI: 10.1016/j.ocarto.2025.100723
Published: 2026-03
Container: Osteoarthritis and Cartilage Open
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ocarto.2025.100723,
  title = {Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 study},
  author = {Pawan Kumar Gupta and Sunil Maheshwari and Joe Joseph Cherian and Vijay Goni and Arun Kumar Sharma and Sujit Kumar Tripathy and Keerthi Talari and Vivek Pandey and Parag Kantilal Sancheti and Saurabh Singh and Syamasis Bandyopadhyay and Naresh Shetty and Surendra Umesh Kamath and Purohit Sharad Prahaldbhai and Jijy Abraham and Suresh Kannan and Nikhil N. Verma and Uday Kumar},
  year = {2026},
  journal = {Osteoarthritis and Cartilage Open},
  doi = {10.1016/j.ocarto.2025.100723},
  url = {https://doi.org/10.1016/j.ocarto.2025.100723}
}

RIS

TY  - JOUR
TI  - Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 study
AU  - Pawan Kumar Gupta
AU  - Sunil Maheshwari
AU  - Joe Joseph Cherian
AU  - Vijay Goni
AU  - Arun Kumar Sharma
AU  - Sujit Kumar Tripathy
AU  - Keerthi Talari
AU  - Vivek Pandey
AU  - Parag Kantilal Sancheti
AU  - Saurabh Singh
AU  - Syamasis Bandyopadhyay
AU  - Naresh Shetty
AU  - Surendra Umesh Kamath
AU  - Purohit Sharad Prahaldbhai
AU  - Jijy Abraham
AU  - Suresh Kannan
AU  - Nikhil N. Verma
AU  - Uday Kumar
PY  - 2026
JO  - Osteoarthritis and Cartilage Open
DO  - 10.1016/j.ocarto.2025.100723
UR  - https://doi.org/10.1016/j.ocarto.2025.100723
ER  -

APA

Gupta, P. K., Maheshwari, S., Cherian, J. J., Goni, V., Sharma, A. K., Tripathy, S. K., Talari, K., Pandey, V., Sancheti, P. K., Singh, S., Bandyopadhyay, S., Shetty, N., Kamath, S. U., Prahaldbhai, P. S., Abraham, J., Kannan, S., Verma, N. N., & Kumar, U. (2026). Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 study. Osteoarthritis and Cartilage Open. https://doi.org/10.1016/j.ocarto.2025.100723

Source records

crossref · retrieved 2026-09-26T06:57:24.458Z